| Landscape of genomic alterations in cervical carcinomas AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu, ... Nature 506 (7488), 371-375, 2014 | 828 | 2014 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation HB Salvesen, SL Carter, M Mannelqvist, A Dutt, G Getz, IM Stefansson, ... Proceedings of the National Academy of Sciences 106 (12), 4834-4839, 2009 | 352 | 2009 |
| Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses G Bredholt, M Mannelqvist, IM Stefansson, E Birkeland, TH Bø, AM Øyan, ... Oncotarget 6 (37), 39676, 2015 | 200 | 2015 |
| Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 178 | 2013 |
| Lack of estrogen receptor-α is associated with epithelial–mesenchymal transition and PI3K alterations in endometrial carcinoma E Wik, MB Ræder, C Krakstad, J Trovik, E Birkeland, EA Hoivik, S Mjos, ... Clinical Cancer Research 19 (5), 1094-1105, 2013 | 169 | 2013 |
| HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer AE Teschendorff, SH Lee, A Jones, H Fiegl, M Kalwa, W Wagner, ... Genome medicine 7, 1-12, 2015 | 165 | 2015 |
| Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development A Jones, AE Teschendorff, Q Li, JD Hayward, A Kannan, T Mould, J West, ... PLoS medicine 10 (11), e1001551, 2013 | 160 | 2013 |
| Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial J Trovik, E Wik, HMJ Werner, C Krakstad, H Helland, I Vandenput, ... European journal of cancer 49 (16), 3431-3441, 2013 | 159 | 2013 |
| Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer J Trovik, E Wik, IM Stefansson, J Marcickiewicz, S Tingulstad, AC Staff, ... Clinical cancer research 17 (10), 3368-3377, 2011 | 152 | 2011 |
| Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31 J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ... Nature communications 4 (1), 1627, 2013 | 136 | 2013 |
| Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer L Alonso-Alconada, L Muinelo-Romay, K Madissoo, A Diaz-Lopez, ... Molecular cancer 13, 1-10, 2014 | 114 | 2014 |
| KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer E Birkeland, E Wik, S Mjøs, EA Hoivik, J Trovik, HMJ Werner, ... British journal of cancer 107 (12), 1997-2004, 2012 | 100 | 2012 |
| Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers MB Raeder, E Birkeland, J Trovik, C Krakstad, S Shehata, S Schumacher, ... PloS one 8 (2), e54873, 2013 | 89 | 2013 |
| Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer AC Staff, J Trovik, EAG Zahl, E Wik, KC Wollert, T Kempf, HB Salvesen Clinical cancer research 17 (14), 4825-4833, 2011 | 89 | 2011 |
| ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas HMJ Werner, A Berg, E Wik, E Birkeland, C Krakstad, K Kusonmano, ... Modern Pathology 26 (3), 428-434, 2013 | 82 | 2013 |
| Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer TA Klingen, Y Chen, H Aas, E Wik, LA Akslen Human pathology 69, 72-80, 2017 | 77 | 2017 |
| Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome C Krakstad, J Trovik, E Wik, IB Engelsen, HMJ Werner, E Birkeland, ... British journal of cancer 106 (10), 1682-1688, 2012 | 74 | 2012 |
| Lipocalin 2 expression is associated with aggressive features of endometrial cancer M Mannelqvist, IM Stefansson, E Wik, K Kusonmano, MB Raeder, ... BMC cancer 12, 1-7, 2012 | 66 | 2012 |
